{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:08:30Z","timestamp":1788307710251,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04382-7","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T13:34:30Z","timestamp":1759757670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Changes in frailty, intensive blood pressure treatment, and risks of adverse clinical outcomes: a post hoc analysis of the SPRINT trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaoyun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiange","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"10206","key":"4382_CR1","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365\u201375.","journal-title":"Lancet"},{"issue":"8","key":"4382_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s43587-021-00099-3","volume":"1","author":"SE Howlett","year":"2021","unstructured":"Howlett SE, Rutenberg AD, Rockwood K. The degree of frailty as a translational measure of health in aging. Nat Aging. 2021;1(8):651\u201365.","journal-title":"Nat Aging"},{"issue":"8","key":"4382_CR3","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/eurheartj\/ehab850","volume":"43","author":"W Shrauner","year":"2021","unstructured":"Shrauner W, Lord EM, Nguyen XT, et al. Frailty and cardiovascular mortality in more than 3 million US Veterans. Eur Heart J. 2021;43(8):818\u201326.","journal-title":"Eur Heart J"},{"issue":"37","key":"4382_CR4","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1093\/eurheartj\/ehab468","volume":"42","author":"AA Damluji","year":"2021","unstructured":"Damluji AA, Chung SE, Xue QL, et al. Frailty and cardiovascular outcomes in the national health and aging trends study. Eur Heart J. 2021;42(37):3856\u201365.","journal-title":"Eur Heart J"},{"key":"4382_CR5","unstructured":"World Health Organization. Ageing and health 2024 [Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ageing-and-health]. Accessed 16 Oct 2024."},{"issue":"6","key":"4382_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra2301292","volume":"391","author":"DH Kim","year":"2024","unstructured":"Kim DH, Rockwood K. Frailty in older adults. N Engl J Med. 2024;391(6):538\u201348.","journal-title":"N Engl J Med"},{"issue":"12","key":"4382_CR7","doi-asserted-by":"publisher","first-page":"e024406","DOI":"10.1136\/bmjopen-2018-024406","volume":"8","author":"DL Vetrano","year":"2018","unstructured":"Vetrano DL, Palmer KM, Galluzzo L, et al. Hypertension and frailty: a systematic review and meta-analysis. BMJ Open. 2018;8(12):e024406.","journal-title":"BMJ Open"},{"issue":"12","key":"4382_CR8","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s12603-023-2035-5","volume":"27","author":"H Liu","year":"2023","unstructured":"Liu H, Zhou W, Liu Q, Yu J, Wang C. Global prevalence and factors associated with frailty among community-dwelling older adults with hypertension: a systematic review and meta-analysis. J Nutr Health Aging. 2023;27(12):1238\u201347.","journal-title":"J Nutr Health Aging"},{"issue":"10","key":"4382_CR9","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s12603-022-1850-4","volume":"26","author":"CL Chen","year":"2022","unstructured":"Chen CL, Cai AP, Nie ZQ, Huang YQ, Feng YQ. Systolic blood pressure and mortality in community-dwelling older adults: the role of frailty. J Nutr Health Aging. 2022;26(10):962\u201370.","journal-title":"J Nutr Health Aging"},{"issue":"15","key":"4382_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/archinternmed.2012.2555","volume":"172","author":"MC Odden","year":"2012","unstructured":"Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med. 2012;172(15):1162\u20138.","journal-title":"Arch Intern Med"},{"issue":"24","key":"4382_CR11","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/CIRCULATIONAHA.116.026687","volume":"135","author":"R Ravindrarajah","year":"2017","unstructured":"Ravindrarajah R, Hazra NC, Hamada S, et al. Systolic blood pressure trajectory, frailty, and all-cause mortality >80 years of age: cohort study using electronic health records. Circulation. 2017;135(24):2357\u201368.","journal-title":"Circulation"},{"issue":"5","key":"4382_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/ageing\/afaa028","volume":"49","author":"JAH Masoli","year":"2020","unstructured":"Masoli JAH, Delgado J, Pilling L, Strain D, Melzer D. Blood pressure in frail older adults: associations with cardiovascular outcomes and all-cause mortality. Age Ageing. 2020;49(5):807\u201313.","journal-title":"Age Ageing"},{"issue":"1","key":"4382_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.121.17530","volume":"79","author":"KM Kremer","year":"2022","unstructured":"Kremer KM, Braisch U, Rothenbacher D, Denkinger M, Dallmeier D, ActiFE Study Group. Systolic blood pressure and mortality in community-dwelling older adults: frailty as an effect modifier. Hypertension. 2022;79(1):24\u201332.","journal-title":"Hypertension"},{"issue":"5","key":"4382_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/ageing\/afz072","volume":"48","author":"OM Todd","year":"2019","unstructured":"Todd OM, Wilkinson C, Hale M, et al. Is the association between blood pressure and mortality in older adults different with frailty? A systematic review and meta-analysis. Age Ageing. 2019;48(5):627\u201335.","journal-title":"Age Ageing"},{"issue":"7","key":"4382_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/CIRCULATIONAHA.123.064003","volume":"148","author":"Z Wang","year":"2023","unstructured":"Wang Z, Du X, Hua C, et al. The effect of frailty on the efficacy and safety of intensive blood pressure control: a post hoc analysis of the SPRINT trial. Circulation. 2023;148(7):565\u201374.","journal-title":"Circulation"},{"issue":"10206","key":"4382_CR16","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(19)31785-4","volume":"394","author":"E Dent","year":"2019","unstructured":"Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet. 2019;394(10206):1376\u201386.","journal-title":"Lancet"},{"key":"4382_CR17","doi-asserted-by":"crossref","unstructured":"Travers J, Romero-Ortuno R, Langan J, et al. Building resilience and reversing frailty: a randomised controlled trial of a primary care intervention for older adults. Age Ageing. 2023;52(2).","DOI":"10.1093\/ageing\/afad012"},{"issue":"12","key":"4382_CR18","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/eurheartj\/ehad885","volume":"45","author":"D He","year":"2024","unstructured":"He D, Wang Z, Li J, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J. 2024;45(12):1058\u201368.","journal-title":"Eur Heart J"},{"issue":"Supplement_1","key":"4382_CR19","doi-asserted-by":"publisher","first-page":"269-","DOI":"10.1093\/geroni\/igaa057.862","volume":"4","author":"SA Snih","year":"2020","unstructured":"Snih SA, Rodriguez M, Chou LN, Markides KS, Ottenbacher K. Frailty and trajectories of blood pressure among older Mexican Americans over time. Innov Aging. 2020;4(Supplement_1):269-.","journal-title":"Innov Aging"},{"issue":"4","key":"4382_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41440-023-01499-1","volume":"47","author":"HY Wang","year":"2024","unstructured":"Wang HY, Wang J, Wang Q, Yang C, Huang Y, Chen M. Blood pressure in the longevous population with different status of hypertension and frailty. Hypertens Res. 2024;47(4):959\u201369.","journal-title":"Hypertens Res"},{"issue":"5","key":"4382_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","volume":"11","author":"WT Ambrosius","year":"2014","unstructured":"Ambrosius WT, Sink KM, Foy CG, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11(5):532\u201346.","journal-title":"Clin Trials"},{"issue":"9","key":"4382_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"7","key":"4382_CR23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","volume":"62","author":"K Rockwood","year":"2007","unstructured":"Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62(7):722\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"4382_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/gerona\/glv228","volume":"71","author":"NM Pajewski","year":"2016","unstructured":"Pajewski NM, Williamson JD, Applegate WB, et al. Characterizing frailty status in the systolic blood pressure intervention trial. J Gerontol A Biol Sci Med Sci. 2016;71(5):649\u201355.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"4382_CR25","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/gerona\/glaa003","volume":"75","author":"IY Jang","year":"2020","unstructured":"Jang IY, Jung HW, Lee HY, Park H, Lee E, Kim DH. Evaluation of clinically meaningful changes in measures of frailty. J Gerontol A Biol Sci Med Sci. 2020;75(6):1143\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"4382_CR26","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/gerona\/glaa084","volume":"75","author":"O Theou","year":"2020","unstructured":"Theou O, van der Valk AM, Godin J, et al. Exploring clinically meaningful changes for the frailty index in a longitudinal cohort of hospitalized older patients. J Gerontol A Biol Sci Med Sci. 2020;75(10):1928\u201334.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"19","key":"4382_CR27","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2146\/ajhp040558","volume":"62","author":"L Wen","year":"2005","unstructured":"Wen L, Badgett R, Cornell J. Number needed to treat: a descriptor for weighing therapeutic options. Am J Health Syst Pharm. 2005;62(19):2031\u20136.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"4382_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ageing\/afaa219","volume":"50","author":"R O\u2019Caoimh","year":"2020","unstructured":"O\u2019Caoimh R, Sezgin D, O\u2019Donovan MR, et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing. 2020;50(1):96\u2013104.","journal-title":"Age Ageing"},{"issue":"4","key":"4382_CR29","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s11357-023-00771-z","volume":"45","author":"Y Ye","year":"2023","unstructured":"Ye Y, Noche RB, Szejko N, et al. A genome-wide association study of frailty identifies significant genetic correlation with neuropsychiatric, cardiovascular, and inflammation pathways. Geroscience. 2023;45(4):2511\u201323.","journal-title":"Geroscience"},{"issue":"12","key":"4382_CR30","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1093\/gerona\/glab315","volume":"77","author":"R Westbrook","year":"2022","unstructured":"Westbrook R, Zhang C, Yang H, et al. Metabolomics-based identification of metabolic dysfunction in frailty. J Gerontol A Biol Sci Med Sci. 2022;77(12):2367\u201372.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"4382_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243\u201378.","journal-title":"Cell"},{"key":"4382_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.arr.2019.01.010","volume":"50","author":"G Kojima","year":"2019","unstructured":"Kojima G, Taniguchi Y, Iliffe S, Jivraj S, Walters K. Transitions between frailty states among community-dwelling older people: a systematic review and meta-analysis. Ageing Res Rev. 2019;50:81\u20138.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4382_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12933-024-02379-9","volume":"23","author":"P Zeng","year":"2024","unstructured":"Zeng P, Li M, Cao J, Zeng L, Jiang C, Lin F. Association of metabolic syndrome severity with frailty progression among Chinese middle and old-aged adults: a longitudinal study. Cardiovasc Diabetol. 2024;23(1):302.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"4382_CR34","doi-asserted-by":"publisher","first-page":"e0178383","DOI":"10.1371\/journal.pone.0178383","volume":"12","author":"Z Feng","year":"2017","unstructured":"Feng Z, Lugtenberg M, Franse C, et al. Risk factors and protective factors associated with incident or increase of frailty among community-dwelling older adults: a systematic review of longitudinal studies. PLoS One. 2017;12(6):e0178383.","journal-title":"PLoS One"},{"issue":"5","key":"4382_CR35","doi-asserted-by":"publisher","first-page":"igac032","DOI":"10.1093\/geroni\/igac032","volume":"6","author":"S Shakya","year":"2022","unstructured":"Shakya S, Bajracharya R, Ledbetter L, Cary MP. The association between cardiometabolic risk factors and frailty in older adults: a systematic review. Innov Aging. 2022;6(5):igac032.","journal-title":"Innov Aging"},{"issue":"2","key":"4382_CR36","doi-asserted-by":"publisher","first-page":"e0228821","DOI":"10.1371\/journal.pone.0228821","volume":"15","author":"SHF Macdonald","year":"2020","unstructured":"Macdonald SHF, Travers J, Sh\u00e9 \u00c9N, et al. Primary care interventions to address physical frailty among community-dwelling adults aged 60 years or older: a meta-analysis. PLoS One. 2020;15(2):e0228821.","journal-title":"PLoS One"},{"issue":"4","key":"4382_CR37","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/17437199.2018.1488601","volume":"12","author":"H Gwyther","year":"2018","unstructured":"Gwyther H, Bobrowicz-Campos E, Luis Alves Ap\u00f3stolo J, Marcucci M, Cano A, Holland C. A realist review to understand the efficacy and outcomes of interventions designed to minimise, reverse or prevent the progression of frailty. Health Psychol Rev. 2018;12(4):382\u2013404.","journal-title":"Health Psychol Rev"},{"issue":"1","key":"4382_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12877-019-1039-9","volume":"19","author":"MC Wang","year":"2019","unstructured":"Wang MC, Li TC, Li CI, et al. Frailty, transition in frailty status and all-cause mortality in older adults of a Taichung community-based population. BMC Geriatr. 2019;19(1):26.","journal-title":"BMC Geriatr"},{"issue":"1","key":"4382_CR39","doi-asserted-by":"publisher","first-page":"26498","DOI":"10.1038\/s41598-024-78312-7","volume":"14","author":"MK Son","year":"2024","unstructured":"Son MK, Lee K. Frailty transition and burden on mortality risk in middle-aged and older population: a prospective cohort study. Sci Rep. 2024;14(1):26498.","journal-title":"Sci Rep"},{"issue":"1","key":"4382_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12877-024-04682-2","volume":"24","author":"Z Wang","year":"2024","unstructured":"Wang Z, Ruan H, Li L, Song N, He S. Association of changes in frailty status with the risk of all-cause mortality and cardiovascular death in older people: results from the Chinese longitudinal healthy longevity survey (CLHLS). BMC Geriatr. 2024;24(1):96.","journal-title":"BMC Geriatr"},{"issue":"9868","key":"4382_CR41","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752\u201362.","journal-title":"Lancet"},{"issue":"1","key":"4382_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ageing\/aft160","volume":"43","author":"M Cesari","year":"2013","unstructured":"Cesari M, Gambassi G, van Kan G, Vellas B. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing. 2013;43(1):10\u20132.","journal-title":"Age Ageing"},{"key":"4382_CR43","doi-asserted-by":"publisher","first-page":"6759521","DOI":"10.1155\/2020\/6759521","volume":"2020","author":"M Nwadiugwu","year":"2020","unstructured":"Nwadiugwu M. Frailty and the risk of polypharmacy in the older person: enabling and preventative approaches. J Aging Res. 2020;2020:6759521.","journal-title":"J Aging Res"},{"key":"4382_CR44","doi-asserted-by":"crossref","unstructured":"Chen YZ, Huang ST, Wen YW, Chen LK, Hsiao FY. Combined effects of frailty and polypharmacy on health outcomes in older adults: frailty outweighs polypharmacy. J Am Med Dir Assoc. 2021;22(3).","DOI":"10.1016\/j.jamda.2020.07.019"},{"issue":"6","key":"4382_CR45","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269\u2013324.","journal-title":"Hypertension"},{"issue":"7","key":"4382_CR46","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/CIRCRESAHA.118.313236","volume":"124","author":"A Benetos","year":"2019","unstructured":"Benetos A, Petrovic M, Strandberg T. Hypertension management in older and frail older patients. Circ Res. 2019;124(7):1045\u201360.","journal-title":"Circ Res"},{"issue":"5","key":"4382_CR47","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s41440-023-01200-6","volume":"46","author":"A Toba","year":"2023","unstructured":"Toba A, Ishikawa J. Current topics of frailty in association with hypertension and other medical conditions. Hypertens Res. 2023;46(5):1188\u201394.","journal-title":"Hypertens Res"},{"key":"4382_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12916-015-0328-1","volume":"13","author":"J Warwick","year":"2015","unstructured":"Warwick J, Falaschetti E, Rockwood K, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78.","journal-title":"BMC Med"},{"issue":"24","key":"4382_CR49","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2016.7050","volume":"315","author":"JD Williamson","year":"2016","unstructured":"Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years a randomized clinical trial. JAMA. 2016;315(24):2673\u201382.","journal-title":"JAMA"},{"issue":"6","key":"4382_CR50","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/ndt\/gfz275","volume":"35","author":"J Vanmassenhove","year":"2020","unstructured":"Vanmassenhove J, Van Biesen W, Lameire N. The interplay and interaction between frailty and acute kidney injury. Nephrol Dial Transplant. 2020;35(6):911\u20135.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04382-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04382-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04382-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:25:01Z","timestamp":1759764301000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04382-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4382"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04382-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a post hoc analysis of the SPRINT trial. The SPRINT trial was approved by the institutional review board of each participating study site, and all participants provided written informed consent. The full name of each participating study site has been published (available at ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"536"}}